Raut L, Bohara VV, Ray SS, Chakrabarti P, Chaudhuri U. Chronic myeloid leukemia in children and adolescents: A single center experience from Eastern India.
South Asian J Cancer 2014;
2:260-4. [PMID:
24455654 PMCID:
PMC3889057 DOI:
10.4103/2278-330x.119891]
[Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
Context:
Chronic Myeloid Leukemia (CML) constitutes around 3% of leukemia in the children and adolescent age group.
Aims:
The aim of the study was to evaluate the characteristics at presentation and the treatment outcome of CML in the children and adolescent age group.
Settings and Design:
Retrospective analysis was carried out at a single center in India.
Materials and Methods:
Thirteen patients (≤17 years) attending CML outdoor from April 2008 to August 2012 were included in the analysis.
Statistical Analysis Used:
The mean and median of various parameters were calculated using a Microsoft excel sheet. SPSS 16.0 version software was used to calculate OS and PFS.
Results:
CML-CP was the most common phase at presentation. Maximum patients belonged to the 14 - 17 year old age group. Disease was common in the male sex. Splenic discomfort and asthenia were the most common symptoms and splenomegaly was the most common sign.
Conclusions:
The treatment with Imatinib was effective and well-tolerated.
Collapse